Benzinga | Aug 6, 2021 01:19PM EDT

Qiagen Receives U.S. FDA Emergency Use Authorization For Rapid Portable Test That Can Analyze Over 30 Samples/Hour For SARS-Cov-2 Antigen

-Reuters